The proteomic analysis combined with functional verification indicated that CDR1as overexpression could promote the proliferation and cell cycle progression of HCC cells partly via modulation of epidermal growth factor receptor (EGFR) signaling by controlling miR-7 expression. The gene discussed is EGFR; the disease is hepatocellular carcinoma.